论文部分内容阅读
目的:探讨安舒环与TCu220宫内节育器用于临床妇科的实际价值。方法:将我院于2014年6月-2016年6月间收治的84例自愿接受宫内节育器放置妇女的临床资料作为样本,按照放置节育器类型的不同将其分为实验组与对照组(分别44例、40例),前者给予安舒环宫内放置,后者给予TCu220放置。从所有妇女节育器放置后不良反应的发生情况,如白带增多、腰痛、腹痛、月经量增多、出血等相关情况进行统计,并在后期走访过程中对于患者节育器总续用率进行记录分析。结果:与对照组相比,实验组妇女临床不良反应发生几率显著降低(对照组25%,实验组9.1%),P<0.05;实验组总续用率明显高于对照组(90.9%>80.0%),P<0.05。结论:与TCu220宫内节育器相比,安舒环宫内节育器在临床妇科应用方面更具有优势,能够明显降低妇女不良反应发生几率,极大减少其痛苦,更为妇女群体接受,故值得进一步研究与应用。
Objective: To investigate the practical value of Anshu ring and TCu220 intrauterine device in clinical gynecology. Methods: The clinical data of 84 women who were placed on IUD in our hospital from June 2014 to June 2016 were selected as the samples, which were divided into experimental group and control group according to different types of IUD placement (44 cases, 40 cases, respectively). The former was given intrauterine arshoes and the latter was given TCu220. Adverse effects such as increased leucorrhea, low back pain, abdominal pain, increased menstrual flow, and bleeding were recorded from all women’s IUDs. Statistical analyzes were performed on the prevalence of IUDs during the follow-up visit. Results: Compared with the control group, the incidence of clinical adverse reactions in the experimental group was significantly reduced (25% in the control group and 9.1% in the experimental group), P <0.05; the total continued rate in the experimental group was significantly higher than that in the control group (90.9%> 80.0 %), P <0.05. Conclusion: Compared with TCu220 intrauterine device, the Anshu ring IUD has more advantages in clinical and gynecological application, which can significantly reduce the incidence of adverse reactions in women, greatly reducing the pain and acceptance of women, so it is worthwhile Further research and application.